Jeffrey Sherman — Xeris Biopharma Director Compensation (2025)

What they were paid

Xeris Biopharma Director Compensation Table · all 2 fiscal years held

In US dollars, as Xeris Biopharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal year	Cash fees	Stock awards	Option awards	Other	Total
FY2025	$64,000	$221,500	$0	$0	$285,500
FY2024	$62,500	$121,500	—	—	$184,000

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Xeris Biopharma Holdings, Inc. DEF 14A filed April 23, 2026, accession 0001867096-26-000021, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

Xeris Biopharma pays directors a $50,000 cash retainer and $221,500 in RSUs.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance

The rest of the Xeris Biopharma board

FY2025 · as the company reported each

Director	Role	FY2025 total
BJ Bormann	Independent Director	$294,500
Dawn Halkuff	Independent Director	$290,500
Garheng Kong	Independent Director	$281,500
James Brady	Independent Director	$606,984
John Johnson	Independent Director	$276,500
John Shannon	Director	$0
Marla Persky	Chair of the Board	$326,500

The full Xeris Biopharma compensation record

free company brief

This page is one director within Xeris Biopharma's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat